Cargando…
Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
OBJECTIVE: To assess satisfaction with the effectiveness and tolerability of treatments in patients with rheumatoid arthritis (RA). METHODS: Patients from the RABBIT register, starting a biological (b) or targeted synthetic (ts) disease-modifying antirheumatic drug (DMARD), or a conventional synthet...
Autores principales: | Schäfer, Martin, Albrecht, Katinka, Kekow, Jörn, Rockwitz, Karin, Liebhaber, Anke, Zink, Angela, Strangfeld, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722277/ https://www.ncbi.nlm.nih.gov/pubmed/33051270 http://dx.doi.org/10.1136/rmdopen-2020-001290 |
Ejemplares similares
-
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register
por: Redeker, Imke, et al.
Publicado: (2022) -
Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2023) -
Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy
por: Callhoff, Johanna, et al.
Publicado: (2015) -
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
por: Meissner, Yvette, et al.
Publicado: (2016) -
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
por: Lauper, Kim, et al.
Publicado: (2022)